leisure time
Previous article:
Cancer drug shortages should be causing more outrage
Next article: In boost for rare disease push, AstraZeneca to buy Amolyt Pharma
Next article: In boost for rare disease push, AstraZeneca to buy Amolyt Pharma
focus
knowledge
-
Readout LOUD podcast: The Sarepta saga, decoding biotech hype
2025-09-28 18:30 -
Sarepta Duchenne therapy fails to meet primary endpoint in trial
2025-09-28 17:56 -
John Green on his newest strategy for fighting tuberculosis
2025-09-28 16:53 -
Key Senate panel to consider PBM, drug pricing reform package
2025-09-28 16:37 -
Medicare proceeds with plan to claw back hospital funds
2025-09-28 16:07 -
Medicare must police algorithms in Medicare Advantage, Dems say
2025-09-28 16:06